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OBJECTIVE—Hypothalamic leptin resistance is found in most
common forms of obesity, such as diet-induced obesity, and is
associated with increased expression of suppressor of cytokine
signaling 3 (Socs3) in the hypothalamus of diet-induced obese
animals. This study aims to determine the functional conse-
quence of Socs3 upregulation on leptin signaling and obesity, and
to investigate whether Socs3 upregulation affects energy balance
in a cell type–speciﬁc way.
RESEARCH DESIGN AND METHODS—We generated trans-
genic mice overexpressing Socs3 in either proopiomelanocortin
(POMC) or leptin receptor–expressing neurons, at levels similar
to what is observed in diet-induced obesity.
RESULTS—Upregulation of Socs3 in POMC neurons leads to
impairment of STAT3 and mammalian target of rapamycin
(mTOR)–S6K-S6 signaling, with subsequent leptin resistance,
obesity, and glucose intolerance. Unexpectedly, Socs3 upregula-
tion in leptin receptor neurons results in increased expression of
STAT3 protein in mutant hypothalami, but does not lead to
obesity.
CONCLUSIONS—Our study establishes that Socs3 upregula-
tion alone in POMC neurons is sufﬁcient to cause leptin resis-
tance and obesity. Socs3 upregulation impairs both STAT3 and
mTOR signaling before the onset of obesity. The lack of obesity
in mice with upregulated Socs3 in leptin receptor neurons
suggests that Socs3’s effect on energy balance could be cell type
speciﬁc. Our study indicates that POMC neurons are important
mediators of Socs3’s effect on leptin resistance and obesity, but
that other cell types or alteration of other signaling regulators
could contribute to the development of obesity. Diabetes 59:
894–906, 2010
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onsumption of fat-rich diets has contributed to
an increase in obesity. Leptin, an adipose-de-
rived hormone, acts in the brain to decrease
feeding and increase energy expenditure. How-
ever, leptin’s anorexigenic effects are diminished in diet-
induced obese animals despite an increase in circulating
levels, a condition termed leptin resistance. This phenom-
enon is observed in the majority of obese patients who are
unresponsive to exogenous leptin treatment (1). Leptin
binds to the long form of the leptin receptor (LepRb)
activating signal transducer and activator of transcription
3 (STAT3) (2). Leptin also activates phosphatidylinositol 3
kinase–mammalian target of rapamycin (mTOR)–S6K sig-
naling in hypothalamic neurons (3–5). A hallmark of
diet-induced leptin resistance is impairment of leptin
signaling in hypothalamic neurons (6–10). Intriguingly,
leptin resistance appears to be region speciﬁc with the
arcuate nucleus being more severely affected (8,10).
To date, the mechanism of leptin resistance remains
poorly understood. Socs3 is a plausible causal factor, as its
expression is elevated in the hypothalamus during early
stages of high-fat feeding (8). Socs3 binds to Tyr985 of
leptin receptor and Janus kinase 2, inhibiting leptin-in-
duced STAT3 signaling (11). Mice with deletion of Socs3 in
the whole brain or proopiomelanocortin (POMC) neurons,
key leptin target neurons in the arcuate nucleus of the
hypothalamus, are resistant to diet-induced obesity
(12,13). However, there are other negative regulators of
leptin signaling, such as protein tyrosine phosphatase 1B,
whose deletion protects against diet-induced obesity (14–
17). Thus, it is unclear whether leptin resistance requires
the action of multiple factors, or whether it can be induced
by Socs3 upregulation alone. It is also unknown whether
Socs3 upregulation in different subsets of leptin target
neurons acts additively to induce leptin resistance. Al-
though Socs3 is known to inhibit phosphorylation of
STAT3 (pSTAT3) signaling, it is not clear whether Socs3
affects other leptin signaling pathways in hypothalamic
neurons. In this study, we generated transgenic mice in
which Socs3 is modestly overexpressed in either POMC or
LepRb neurons. We show that Socs3 upregulation in
POMC neurons antagonizes pSTAT3 and mTOR-S6K sig-
naling with subsequent leptin resistance and obesity. Sur-
prisingly, overexpression of Socs3 in LepRb neurons does
not cause obesity, suggesting that Socs3 plays a cell
type–speciﬁc role in energy balance regulation.
RESEARCH DESIGN AND METHODS
Generation of transgenic mice that express Cre-activatable Socs3
allele. A DNA fragment containing the cytomegalovirus (CMV) promoter was
released from plasmid PHMCMV5 and subcloned into the BamHI site of the
pE1sp1A vector (kindly provided by Dr. Mark Kay, Stanford University). A
full-length mouse Socs3 cDNA was placed behind a loxP-ﬂanked polyadenyl-
ation cassette (4xpA; ﬂoxed “stop” cassette) derived originally from
pROSA26-R (18). The resulting fragment was subcloned into the pE1sp1A
downstream of the CMV promoter. The stop cassette’s effectiveness has been
validated (4). A linear 10-kilobase DNA fragment containing CMV-ﬂoxed
stop-Socs3-polyA sequences was puriﬁed and microinjected into fertilized
eggs from C57BL6/J donors. The sequence of the entire Socs3 cDNA was
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CCTCGACCTGCAGCC and TACACAGTCGAAGCGGGGAACTGG.
Mouse genetics. Tg.Nestin-Cre mice were purchased from The Jackson
Laboratory. Generation and use of the LepRb-Cre mice were previously
described (19,20). Tg.Pomc-Cre mice have been validated by multiple research
groups (4,20–24). These mice were backcrossed to C57BL6/J background for
eight generations. LepRb-Cre/ or Tg.Pomc-Cre/ female mice were crossed
with Tg.CMV-Flox-stop-Socs3 male mice described above. The control cohort
contains three different genotypes: /;/ mice, /;Tg.CMV-Flox-stop-
Socs3/ mice, and Tg.LepRb-Cre or Tg.Pomc-Cre/;/ mice. No phenotypic
differences were seen among different control groups so they were pooled for
analysis. Mutant mice are doubly heterozygous for the Socs3 allele and the
POMC-Cre or LepRb-Cre allele, and are designated POMC-Socs3-OE or
LepRb-Socs3-OE. For all experiments, male age-matched controls and mu-
tants were used with the exception of Fig. 1D and Fig. 1E, for which both
males and females were used. Mice were housed in barrier facility with a
0700-light/1900-dark cycle. Mice were fed standard mouse chow (21.6% kcal
from fat; Purina mouse diet 5058) or high-fat diet (60% kcal from fat; Research
Diet D12492). All experiments were performed under a protocol approved by
University of California San Francisco Institutional Animal Care and Use
Committee.
Body composition analysis. Lean and fat mass in live mice was determined
by dual-energy X-ray absorptiometry (DEXA) using a PIXImus II (Lunar). The
DEXA apparatus was calibrated with a phantom mouse with manufacturer-set
value of bone density and fat mass. Fat pad weights were determined by
postmortem dissection.
Leptin sensitivity and indirect calorimetry. Mice were injected intraperi-
toneally twice daily (0900 and 1700) with saline for 3 days and leptin 2.5 mg/kg
(National Hormone Peptide Program) twice on the fourth day. Food intake
was calculated as the average of the 3-day saline treatment and compared with
the 24-h period after the ﬁrst leptin injection. To measure oxygen consump-
tion, mice were analyzed for body composition, placed into an Oxymax
Respirometer (Columbus Instruments), and allowed 24 h to acclimatize before
taking measurements. Oxygen consumption is normalized to lean body mass
as determined by DEXA analysis.
Measurement of leptin, insulin, and glucose levels. Blood was collected
via mandibular vein puncture under either fed (leptin) or 4- to 6-h–fasted
(insulin) conditions. Hormones were measured with a leptin ELISA kit
(Crystal Chem) and an insulin ELISA kit (Alpco). For glucose tolerance tests,
mice were fasted for 6 h, and injected intraperitoneally with glucose (1.5 g/kg).
Blood glucose was measured with a glucometer (Freestyle; Abbott Diabetes
Care) at indicated times. For insulin tolerance tests, mice were fasted for 2 h,
and intraperitoneally injected with insulin (1 U/kg, Novolin R). Blood glucose
was measured as above.
Western blotting analysis. Mice were injected with either saline or leptin 3
mg/kg i.p., and after 1 h the hypothalamus was dissected and lysed by
sonication in cell lysis buffer (Cell Signaling). Lysates were quantiﬁed with
Bradford reagent (Bio-Rad Laboratories). Membranes were blocked with 5%
milk in Tris-buffered saline with Tween for 1 h and incubated with primary
antibody overnight at 4°C. Blots were incubated in secondary antibody (1:2000
goat anti-rabbit–conjugated horseradish peroxidase) for1ha troom temper-
ature. Primary antibodies used are as follows: polyclonal anti-STAT3 1:1,000,
polyclonal anti–phospho (Tyr-705)-STAT3 1:1,000 (Cell Signaling Technology),
and polyclonal anti–glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
1:2000 (Santa Cruz Biotechnology).
mRNA expression. Extraction of hypothalamic RNA was performed as
previously described (20,25). RNA (1 g) was reverse transcribed, then PCR
ampliﬁed using a 7900HT Fast Real-Time PCR System (Applied Biosystems).
-actin was used as internal control. TaqMan gene expression assays (Applied
Biosystems) were used for Pomc, Agrp, Npy, Socs3, and -actin detection. A
custom TaqMan gene expression assay (Applied Biosystems) was used for
Tg.Socs3 detection: CTTATCGATACCGTCGACCTC and ACTTGCTGTGGGT
GACCA and probe: AGATCCACGCTGGCTCCGTG.
Immunoﬂuorescence analysis. LepRb-Soc3-OE or POMC-Socs3-OE fed
mutant and control mice were injected intraperitoneally with leptin 3 mg/kg or
saline, and perfused with 4% paraformaldehyde 45 min later. Immunoﬂuores-
cence analysis was carried out as previously described (25).
Cell size and cell counting. All immunoﬂuorescence images were blinded
before analysis. ACTH-, pSTAT3-, or pS6-positive cells from matched sections
ranging from bregma 1.22 to 1.58 (Paxinos Mouse Brain Atlas) were
counted. For cell size determination, the average area and perimeter of
ACTH-positive cells were analyzed using the “analyze particles” function in
ImageJ software. Results were veriﬁed by investigators to rule out nonspeciﬁc
signals.
Statistics. Analysis of compared groups was performed by either two-tailed
Student t test or two-way ANOVA (J.M.P.) as speciﬁed in ﬁgure legends.
Values represent mean  SEM.
RESULTS
Generation of transgenic mice to overexpress Socs3
in a cell type–speciﬁc manner. To investigate Socs3
upregulation in speciﬁc neuronal subtypes, we generated
transgenic mice carrying a wild-type Socs3 transgene
(Tg.Socs3) placed downstream of a ﬂoxed transcriptional
stop cassette (Fig. 1A). The stop cassette is removed upon
Cre-mediated recombination, allowing Tg.Socs3 to be ex-
pressed under the constitutively active CMV promoter.
Mice carrying the conditional Socs3 allele (Tg.Socs3-OE)
were born in Mendelian ratio and were indistinguishable
from their wild-type littermates in growth and body weight
(Fig. 1B). By weaning, Nestin-Socs3-OE mice were 33%
smaller than Tg.Nestin-Cre control mice (mutants 6.46 
0.24 g, controls 9.62  0.37). This reduction in body weight
was observed in two independent Tg.Socs3-OE lines de-
rived from different transgenic founders, suggesting that
the phenotype was not due to position effects of transgene
integration.
Hypothalamic Socs3 expression is very low under basal
conditions (26), making it difﬁcult to quantify a modest
change by in situ approach. We thus crossed Tg.Socs3-OE
with Tg.Nestin-Cre mice (the resultant mutants were
named Nestin-Socs3-OE) so that Tg.Socs3 would be over-
expressed in the entire brain, making quantitative assays
possible. Using PCR primers speciﬁc for the Tg.Socs3
transgene, Tg.Socs3 mRNA expression was detected in the
brain where Nestin-Cre was expressed, but not in periph-
eral tissues, such as liver, where Nestin-Cre was not
expressed (Fig. 1C). This result conﬁrms that expression
of Tg.Socs3 is Cre dependent. By real-time RT-PCR, Socs3
expression was elevated about twofold in the hypothala-
mus of 0.5-week-old Nestin-Socs3-OE mutants (Fig. 1D).
This age was chosen because no phenotypic difference
was detected between controls and mutants at this age.
This increase in Socs3 expression would likely persist into
adulthood because CMV promoter activity is constitutive
and endogenous Socs3 expression does not change signif-
icantly between 0.5 and 8 weeks (Fig. 1E) and in mid-
adulthood (27). This magnitude of Socs3 overexpression is
within the physiologic range of Socs3 upregulation (two-
fold) observed in diet-induced obesity (8,28). However, it
should be acknowledged that this quantiﬁcation method
could potentially lead to slight overestimation or underes-
timation of Socs3 overexpression in certain cells.
Socs3 upregulation in POMC neurons does not affect
POMC number, cell size, projection outgrowth, or mRNA
expression. If diet-induced leptin resistance and obesity
are caused by the upregulation of Socs3, then upregulating
Socs3 in neuronal cell types important for energy balance
under normal chow-fed conditions should lead to leptin
resistance and obesity. To explore this, we crossed Tg.
Socs3-OE mice with Tg.Pomc-Cre mice (4,20–24). POMC-
Socs3-OE mutant mice (Tg.Pomc-Cre/, Tg.Socs3-OE/)
were born at Mendelian ratio and were phenotypically indis-
tinguishable from control littermates in early adulthood.
Cre-mediated recombination was observed in developing
Tg.Pomc-Cre embryos as early as embryonic day 13.5 post-
coitus, indicating the timing of Socs3 upregulation in these
neurons.
We investigated whether Socs3 upregulation in POMC
neurons resulted in any developmental defects. Hypotha-
lamic sections were prepared from 6-week-old weight-
matched control and POMC-Socs3-OE mice. The number
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Fig. 1, available in an online appendix at http://diabetes.
diabetesjournals.org/cgi/content/full/db09-1024/DC1), as
were POMC projection patterns (supplementary Fig. 2).
We also examined whether Socs3 upregulation in POMC
neurons altered POMC expression. POMC-Socs3-OE mu-
tants and controls were killed at 8 weeks and 25–26 weeks
of age. RNA was extracted from hypothalamic tissues and
expression of Pomc and Agrp was analyzed by real-time
PCR. No signiﬁcant difference in Pomc or Agrp expression
was detected at 8 weeks, although a slight but not signif-
icant decrease in Pomc expression was detected at 25–26
weeks (supplementary Fig. 3A and B). No difference in
pituitary Pomc expression was observed (supplementary
Fig. 3C). Socs3 expression was not altered (supplementary
Fig. 3E). This is likely due to the fact that POMC neurons
represent only a very small fraction of total cells in the
arcuate nucleus, and the modest overexpression of
Socs3 in these neurons would be masked when whole
hypothalamus was analyzed.
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FIG. 1. Generation and characterization of transgenic mice that express Cre-activatable Socs3. A: Transgenic construct to overexpress Socs3 in
a Cre-activatable way. In cells in which Cre is absent, Socs3 is not expressed because of the upstream stop cassette, which consists of four copies
of polyadenylation signal (pA). In cells in which Cre is expressed, the stop cassette is removed and Socs3 expression is driven by the CMV
promoter. Nomenclature of mice used in this study is listed. B: Transgenic mice carrying the Tg.Socs3-OE allele did not show a difference in body
weight (Tg.Socs3-OE/) compared with wild-type (/) controls (controls n  6–30, Tg.Socs3-OE n  5–20). C: Transgenic Socs3 expression is
Cre dependent. Tg.Socs3-OE mice were crossed with mice carrying Nestin-Cre. Semiquantitative real-time RT-PCR showing differential
expression of transgenic Socs3 (Tg.Socs3) in the hypothalamus where Nestin-Cre is expressed, and in liver where Nestin-Cre is not expressed.
Primers were speciﬁc to the Socs3 transgene. Hyp, hypothalamus; Liv, liver. D: Socs3 mRNA expression was analyzed in 0.5-week-old control and
Nestin-Socs3-OE mutant mice (controls n  12, mutants n  6). E: Hypothalamic Socs3 mRNA expression was analyzed in 0.5- and 8-week-old
wild-type C57BL6/J mice (n  6–8). All mice were fed a chow diet. *P < 0.05 by Student t test.
REGULATION OF ENERGY BALANCE BY Socs3
896 DIABETES, VOL. 59, APRIL 2010 diabetes.diabetesjournals.orgOverexpression of Socs3 in POMC neurons results in
increased body weight and adiposity. At 8 weeks of
age, both lean and fat mass did not differ in controls and
POMC-Socs3-OE mutants as determined by DEXA anal-
ysis (Fig. 2B). Body length was also identical (controls
91.3  0.6 mm vs. mutants 92.8  1.0). However, starting
from 15 weeks, mutant mice displayed a modest but
signiﬁcant increase in body weight (Fig. 2A), attribut-
able to a signiﬁcant increase in fat mass (Fig. 2B).
Plasma leptin levels were elevated nearly twofold in
mutants, consistent with elevated body adiposity (Fig.
2C). Thus, upregulation of Socs3 in POMC neurons
results in an age-dependent increase in body weight and
adiposity.
We measured food intake in 8-week-old weight- and
fat-matched mice and found no signiﬁcant difference
(Fig. 2D). However, mutant mice showed signiﬁcantly
lower oxygen consumption during daytime resting pe-
riod, suggesting that POMC-Socs3-OE mice have lower
resting energy expenditure (Fig. 2E and F). Decreased
energy expenditure preceding the onset of obesity sug-
gests that it may be causal for subsequent weight gain.
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FIG. 2. Socs3 overexpression in POMC neurons leads to increased body weight and adiposity, decreased resting energy expenditure, and
resistance to leptin’s anorexigenic effects. A: Body weight of POMC-Socs3-OE on chow diet at indicated ages. Mutants became signiﬁcantly
heavier at 15 weeks of age (controls n  9–13, mutants n  7–10). B: Analysis of lean mass and fat mass by DEXA of POMC-Socs3-OE at 8 and
25 weeks of age (controls n  10, mutants n  8). (C) Plasma leptin levels under fed conditions for 25-week-old POMC-Socs3-OE mice were
signiﬁcantly higher (controls n  9, mutants n  8). D: A 24-h food intake was measured in 8-week-old controls and POMC-Socs3-OE mutant mice
(controls n  11, mutants n  7). E and F: Oxygen consumption was measured in 8-week-old mice, and the values were normalized to lean body
mass of each mouse. Daytime: 1100–1700; nighttime: 1900–0700. A representative trace is shown in F. G: The 9-week-old POMC-Socs3-OE and
control mice were injected intraperitoneally with saline twice daily for 3 consecutive days and leptin (2.5 mg/kg) twice on the fourth day. A 24-h
food intake after leptin treatment was reported as a ratio of food intake after saline treatment (controls n  11, mutants n  7). Data represent
mean  SEM. *P < 0.05, **P < 0.01, between controls and mutants as determined by 2-way ANOVA using litters and genotypes as variables. ns,
nonsigniﬁcant.
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tance to leptin’s anorexigenic effect. To assess
whether Socs3 upregulation in POMC neurons antagonizes
leptin function, POMC-Socs3-OE and control littermates
were analyzed at 9 weeks of age, a time before any
difference in body weight and adiposity could be detected.
DEXA analysis conﬁrmed that experimental groups were
indistinguishable in body weight (controls 26.1  1.0 g vs.
mutants 26.4  0.6) and percentage of adiposity (controls
14.5  1.1 vs. mutants 14.4  0.7). Leptin (2.5 mg/kg)
treatment caused a signiﬁcant decrease in food intake in
the controls compared with saline, but it had no effect on
POMC-Socs3-OE mice (Fig. 2G). This result suggests that
Socs3 expression in POMC neurons causes acute leptin
resistance, an effect that is not secondary to increased
adiposity.
Socs3 upregulation in POMC neurons antagonizes
leptin-stimulated STAT3 signaling. We next investigated
the signaling mechanisms by which Socs3 regulates
leptin function. Six-week-old POMC-Socs3-OE and weight-
matched controls were treated with leptin or saline, and
perfused 45 min later. Hypothalamic sections were pre-
pared and double immunoﬂuorescence analysis was car-
ried out to examine pSTAT3 in POMC neurons. Whereas
pSTAT3 immunoreactivity was barely detectable in saline-
treated animals (supplementary Fig. 4), leptin treatment
dramatically activated pSTAT3 in hypothalamic neurons,
and to a signiﬁcantly lesser extent in the mutant POMC
neurons (Fig. 3A–C). This reduction was not seen in
non-POMC neurons within the arcuate nucleus. This result
suggests that Socs3 upregulation in POMC neurons antag-
onizes leptin-induced STAT3 signaling prior to the obesity
phenotype.
Socs3 upregulation in POMC neurons antagonizes
mTOR-S6 signaling. A recent study shows that leptin-
stimulated mTOR signaling is reduced in the hypothala-
mus of diet-induced obese rodents (10). We therefore
explored whether this pathway could be modulated by
Socs3 upregulation in POMC neurons. mTOR activation
leads to activation of S6K, which phosphorylates its down-
stream target S6. Thus, phosphorylation of S6 protein
(pS6) marks the activation of this pathway. A subset of
cells within the arcuate nucleus expressed pS6 under
basal, fed conditions, and leptin treatment induced a
modest but signiﬁcant increase in the number of pS6-
positive cells in this region (Fig. 4A and B). Interestingly,
we found that mutant animals exhibited a 50% reduction in
pS6 signaling in POMC neurons, and such a reduction was
not observed in non-POMC cells in the arcuate (Fig. 4B
and C). This result indicates that Socs3 upregulation in
POMC neurons causes speciﬁc downregulation of the
mTOR-S6 pathway. The fact that downregulation of pS6
was observed in only POMC neurons before the onset of
obesity suggests that it is a direct consequence of Socs3
upregulation.
Upregulation of Socs3 in leptin receptor neurons
does not cause obesity. LepRb is expressed in many
brain regions (19,29), and POMC neurons represent only a
subset of leptin target neurons. Because upregulation of
Socs3 in POMC neurons causes modest obesity, we antic-
ipated that upregulation of Socs3 in the entire cohort of
leptin receptor neurons would cause a more severe obe-
sity phenotype. To this end, we crossed the Tg.Socs3-OE
mice with LepRb-Cre mice (19,25). Cre-mediated recombi-
nation ﬁrst appears in the hypothalamus of LepRb-Cre
mice around postnatal days 2–3, and recombination is
complete by 8 weeks of age. Mutant mice, designated
LepRb-Socs3-OE, were born at Mendelian ratio with no
gross abnormalities. To our surprise, mutant mice fed a
chow diet did not show a body weight increase, but rather
exhibited a subtle but signiﬁcant reduction in weight
starting at 7 weeks of age (Fig. 5A). Body length and lean
mass were identical between controls and mutants, sug-
gesting that growth was not impaired (Fig. 5B and C).
DEXA analysis revealed a small decrease in fat mass (Fig.
5C), which was consistent with smaller isolated fat depots
(Fig. 5D). Leptin levels in the mutants also trended toward
a decrease (Fig. 5E). In addition, a small but signiﬁcant
decrease in food intake was observed in 6- to 8-week-old
mutants (Fig. 5F).
To determine whether Socs3 overexpression in leptin
receptor neurons affects leptin’s inhibitory effect on food
intake, 8-week-old LepRb-Socs3-OE mice and weight-
matched controls were given leptin (2.5 mg/kg) or saline,
and 24-h food intake was measured. Both controls and
mutants ate less in response to leptin treatment (Fig. 5G).
Taken together, overexpression of Socs3 in leptin receptor
neurons does not augment the obesity phenotype. Ab-
sence of obesity was also observed in LepRb-Socs3-OE
mutants when fed a high-fat diet (Fig. 6).
Upregulation of Socs3 in leptin receptor neurons
leads to upregulation of total STAT3 protein and
increased pSTAT3 signaling. We next investigated
whether leptin-induced STAT3 signaling was altered in
LepRb-Socs3-OE mice and whether this was region spe-
ciﬁc. The 6-week-old control and weight-matched LepRb-
Socs3-OE mutants were injected intraperitoneally with
leptin (3 mg/kg) and perfused 45 min later. pSTAT3
immunoreactive cells were quantiﬁed in arcuate nucleus,
ventromedial hypothalamus, dorsomedial hypothalamus,
and posterior hypothalamic area (Fig. 7A). A small but
signiﬁcant increase in leptin-induced pSTAT3 signal was
found in all regions examined except POMC neurons (Fig.
7B). In a parallel experiment, control and mutant mice
were fasted overnight, injected intraperitoneally with sa-
line or leptin, and killed 1 h later. Western blot analysis of
hypothalamic protein extracts was carried out using equal
total protein input. Consistent with our immunoﬂuores-
cence data, an increase in leptin-induced pSTAT3 signal
was observed in both controls and mutants (Fig. 7C).
Intriguingly, total STAT3 protein also appeared to increase
in mutants, such that leptin-induced pSTAT3 was not
enhanced when normalized to total STAT3 (Fig. 7C). To
conﬁrm the increase in STAT3 expression, a separate
cohort of controls and LepRb-Socs3-OE mutants was
analyzed under basal, fed conditions. When normalized to
total protein level (GAPDH), a signiﬁcant increase in total
STAT3 was observed (Fig. 7D).
Regulation of glucose homeostasis in response to
Socs3 upregulation in POMC or LepRb neurons. To
assess whether Socs3 upregulation affects glucose ho-
meostasis, glucose tolerance tests were carried out.
POMC-Socs3-OE mutant mice exhibited similar glucose
tolerance as controls at 8 weeks of age prior to obesity, but
this was impaired in 25-week-old mutants after exhibiting
a modest obesity phenotype (Fig. 8A and B). Fasting
insulin levels were slightly but not signiﬁcantly higher in
the mutants (controls 3.57  0.65 g/l; mutants 4.63 
0.88; n  8–9), and both genotypes exhibited similar
insulin tolerance (supplementary Fig. 5). Similarly, LepRb-
Socs3-OE mutants showed identical glucose tolerance at 5
weeks of age, and a slight trend toward improved glucose
REGULATION OF ENERGY BALANCE BY Socs3
898 DIABETES, VOL. 59, APRIL 2010 diabetes.diabetesjournals.orgC B
A
0
10
20
30
40
50
60
70
*
P
e
r
c
e
n
t
 
P
O
M
C
 
c
e
l
l
s
 
t
h
a
t
a
r
e
 
p
S
T
A
T
3
 
p
o
s
i
t
i
v
e
N
u
m
b
e
r
 
o
f
 
p
S
T
A
T
3
 
p
o
s
i
t
i
v
e
c
e
l
l
s
 
p
e
r
 
s
e
c
t
i
o
n
Control
POMC-Socs3-OE
Saline Leptin
A
C
T
H
p
S
T
A
T
3
m
e
r
g
e
d
Control POMC-Socs3-OE
0
20
40
60
80
100
Non-POMC POMC Non-POMC POMC
Saline Leptin
*
FIG. 3. Leptin-induced STAT3 signaling is reduced in POMC neurons of POMC-Socs3-OE mice. A: The 6-week-old control and POMC-Socs3-OE
mice were injected with either saline or leptin (3 mg/kg), and perfused 45 min later. Double immunoﬂuorescence analysis was carried out to
examine pSTAT3 in the POMC neurons using antibodies against Tyr705-STAT3 (green) and ACTH (red). B: Number of pSTAT3-positive cells
showed that leptin-induced pSTAT3 was reduced in the POMC but not other arcuate neurons in the mutant mice. C: Percentage of POMC neurons
that are pSTAT3 positive upon saline or leptin treatment in control and mutant mice. n  3–5 sections per mouse from 3–5 mice per group between
bregma 1.22 and 1.58. Data represent mean  SEM. *P < 0.05, between controls and mutants as determined by Student t test. (A high-quality
digital representation of this ﬁgure is available in the online issue.)
A.S. REED AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 59, APRIL 2010 899ACTH pS6 merge
C
o
n
t
r
o
l
 
s
a
l
i
n
e
P
O
M
C
-
S
o
c
s
3
-
O
E
 
s
a
l
i
n
e
C
o
n
t
r
o
l
 
l
e
p
t
i
n
P
O
M
C
-
S
o
c
s
3
-
O
E
 
l
e
p
t
i
n
A
B C
0
4
8
12
16
20
24
28
Non-POMC POMC Non-POMC POMC
N
u
m
b
e
r
 
o
f
 
p
S
6
 
p
o
s
i
t
i
v
e
c
e
l
l
s
 
p
e
r
 
s
e
c
t
i
o
n **
0
2
4
6
8
10
12
14
16
18
20
Saline Leptin
Saline Leptin
%   P O M C   c e l l s   t h a t   a r e   p S 6   p o s i t i v e
Control
POMC-Socs3-OE
**
*
*
*
* ** ****
**
FIG. 4. mTOR-S6 signaling is impaired in POMC neurons of POMC-Socs3-OE mice. A: The 6-week-old control and POMC-Socs3-OE mice were
injected with either saline or leptin (3 mg/kg), and perfused 45 min later. Double immunoﬂuorescence analysis was carried out to examine
phosphorylation of S6 (pS6) in POMC neurons using antibodies against Ser235/236-S6 (green) and ACTH (red). B: Quantiﬁcation of POMC and
pS6-positive cells showed that pS6 was speciﬁcally reduced in POMC neurons but not in other cells in the arcuate nucleus of mutant mice. C:
Percentage of POMC neurons that is positive for pS6 after either saline or leptin treatment. n  3–5 sections per mouse from 3–5 mice per group
between bregma 1.22 and 1.58. Data represent mean  SEM. *P < 0.05, **P < 0.01 for comparisons shown as determined by Student t test.
(A high-quality digital representation of this ﬁgure is available in the online issue.)
REGULATION OF ENERGY BALANCE BY Socs3
900 DIABETES, VOL. 59, APRIL 2010 diabetes.diabetesjournals.orgtolerance in older age (Fig. 8C and D). At 12 weeks of age,
insulin levels were not signiﬁcantly different on chow diet
(controls 1.02  0.14 g/l; mutants 1.25  0.21, n  5–6)
or after 16 weeks on high-fat diet (controls 7.94  1.34;
mutants 7.46  0.66, n  8–12). Fasting glucose levels
were similar at all ages in all genotypes (Fig. 8A–D). Thus,
Socs3 upregulation in either POMC or leptin receptor
neurons does not result in abnormal glucose homeostasis,
and the impaired glucose tolerance seen in older POMC-
Socs3-OE mice is likely secondary to increased adiposity.
DISCUSSION
In this study, we developed a transgenic mouse model to
moderately upregulate Socs3 in POMC or leptin receptor
neurons. We show that Socs3 upregulation alone in POMC
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In contrast, the lack of obesity in LepRb-Socs3-OE mice
was unexpected. Several possible mechanisms exist to
explain this paradox. First, Socs3 may exert different
functions in different leptin receptor neurons. For exam-
ple, deletion of LepRb from POMC or SF1 neurons results
in a similar increase in body weight (30,31). However,
deletion of Socs3 gene from POMC neurons results in
resistance to diet-induced obesity, whereas deletion of
Socs3 in SF1 neurons affects glucose homeostasis but not
body weight (13,32). Alternatively, Socs3 may regulate
energy balance in a leptin-independent way. It has been
shown that cytokine expression increases in diet-induced
obesity, and neuroinﬂammation may play an important
role in the etiology of diet-induced obesity (33–36). Thus,
upregulation of Socs3 could diminish cytokine signaling in
speciﬁc neuronal subtypes, thereby reducing neuroinﬂam-
mation and mitigating weight gain. Finally, compensatory
mechanisms may have developed in the LepRb-Socs3-OE
mice, thus masking the development of obesity. We have
detected increased expression of STAT3 protein in the
hypothalamus of the LepRb-Socs3-OE mice, suggesting
that this may represent a compensatory mechanism to
counter the negative effect of Socs3 upregulation on
STAT3 signaling. At present, the mechanism underlying
increased STAT3 expression is unclear. It has been shown
that leptin-deﬁcient ob/ob mice, which are obese, have
reduced Stat3 expression in the hypothalamus, although
the underlying molecular mechanism has not been eluci-
dated (37). mTOR has been shown to regulate STAT3
protein expression in breast cancer cell lines (38), and we
show here that Socs3 regulates mTOR-S6 signaling path-
way in POMC neurons. However, regulation of mTOR-S6
signaling is complex in that mTOR activities in different
hypothalamic neurons are differentially regulated by leptin
(39). Thus, it is possible that Socs3 upregulation could
differentially regulate mTOR activity in a cell type–speciﬁc
manner, which in turn affects STAT3 expression in dis-
crete cell populations. However, it is equally possible that
altered Stat3 expression in the hypothalamus is a second-
ary effect of altered whole-body physiology.
It is intriguing that upregulation of Socs3 in POMC
neurons results in leptin resistance and obesity. Among all
the brain regions that express leptin receptor, the arcuate
nucleus is uniquely situated next to the median eminence,
a circumventricular organ with an incomplete blood-brain
barrier. Neurons located within the arcuate have direct
contact with circulating leptin, and can respond more
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communication with leptin, insulin, fatty acids, cytokines,
and other inﬂammatory molecules, all of which would
modulate Socs3 expression, POMC neurons likely experi-
ence regular dynamic changes in Socs3 expression. In
contrast, Socs3 expression in other brain regions is nor-
mally low, and any elevation may be perceived as patho-
logic, which could trigger compensatory regulation.
Consistent with this notion, diet-induced Socs3 upregula-
tion as well as leptin resistance are observed primarily in
the arcuate but not other hypothalamic sites (8,10). Taken
together, our results suggest that POMC neurons play an
important role in mediating Socs3’s effects on leptin
resistance and obesity. Although no data are available to
address whether Socs3 is upregulated in a cell type–
speciﬁc fashion during the development of obesity, our
study does not exclude the possibility that Socs3 upregu-
lation in certain subsets of LepRb neurons or in non–
LepRb-expressing cells contributes to obesity. It is also
possible that the concerted action of multiple negative
regulators of leptin signaling is required for development
of severe obesity. In addition, low levels of leptin receptor
are present in some peripheral tissues, although the im-
portance of peripheral leptin action in energy balance
remains controversial (41,42). Because minimal Cre-medi-
ated recombination is detected in peripheral tissues of
LepRb-Cre mice, our current data could not address the
contribution of peripheral Socs3 expression to diet-in-
duced obesity.
Diet-induced leptin resistance manifests as reduced
leptin signaling in hypothalamic neurons, but the timing of
downregulation of different pathways is controversial. It
has been shown that leptin-induced pSTAT3 is reduced in
the arcuate nucleus after 6 days of high-fat feeding (8).
However, in other studies, leptin-induced phosphatidylino-
sitol 3 kinase and mTOR signaling is impaired prior to
defects in pSTAT3 signaling (9,10). Although some of these
discrepancies may be due to differences in diet composi-
tion, age, genetic background, housing condition, or dose
and time course of leptin, these studies suggest that
downregulation of a speciﬁc signaling pathway may trigger
functional leptin resistance and obesity, which in turn
causes downregulation of other leptin signaling pathways.
We show that upregulation of Socs3 in POMC neurons
inhibits pSTAT3 and mTOR pathways concurrently, which
precedes the onset of weight gain. Thus, Socs3 may
induce leptin resistance and obesity by downregulating
multiple leptin pathways concomitantly. It has been
shown that different leptin signaling pathways mediate
speciﬁc subsets of leptin functions, such as energy
balance, glucose homeostasis, growth, reproduction,
and immunity (5,25,28,43,44). Thus, downregulation of
multiple leptin signaling pathways by Socs3 could effec-
tively inhibit these leptin functions, most of which are
impaired in diet-induced obesity. In summary, our study
establishes a causal role for Socs3 in leptin resistance and
obesity, and elucidates its underlying signaling mecha-
nisms. In light of the current obesity epidemic, this study
sheds light on the etiology of diet-induced leptin resistance
and obesity in humans.
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